Related Experiment Videos
[Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease]
J M Raya Sánchez1, G González Brito, L Hernández Nieto
1Servicio de Hematología y Hemoterapia, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife.
Sangre
|December 1, 1994
Abstract:
The most serious complication of curative therapy for Hodgkin's disease is the development of a second malignancy. A patient who developed a low grade non-Hodgkin's lymphoma three years and a half after combined-modality therapy for Hodgkin's disease, is described. It is exceptional this type of non-Hodgkin's lymphoma as a second neoplasm after cytotoxic treatment for Hodgkin's disease. Pathogenic relationships between both processes are discussed.